Literature DB >> 34073969

Imaging Techniques for the Study of Fibrosis in Atrial Fibrillation Ablation: From Molecular Mechanisms to Therapeutical Perspectives.

Francesco De Sensi1, Diego Penela2, David Soto-Iglesias2, Antonio Berruezo2, Ugo Limbruno1.   

Abstract

Atrial fibrillation (AF) is the most prevalent form of cardiac arrhythmia. It is often related to diverse pathological conditions affecting the atria and leading to remodeling processes including collagen accumulation, fatty infiltration, and amyloid deposition. All these events generate atrial fibrosis, which contribute to beget AF. In this scenario, cardiac imaging appears as a promising noninvasive tool for monitoring the presence and degree of LA fibrosis and remodeling. The aim of this review is to comprehensively examine the bench mechanisms of atrial fibrosis moving, then to describe the principal imaging techniques that characterize it, such as cardiac magnetic resonance (CMR) and multidetector cardiac computed tomography (MDCT), in order to tailor atrial fibrillation ablation to each individual.

Entities:  

Keywords:  atrial cardiomyopathies; atrial failure; atrial fibrillation; atrial fibrosis; atrial remodeling; cardiac magnetic resonance; left atrial strain; multi detector computed tomography

Year:  2021        PMID: 34073969     DOI: 10.3390/jcm10112277

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  63 in total

1.  Free-breathing imaging of the heart using 2D cine-GRICS (generalized reconstruction by inversion of coupled systems) with assessment of ventricular volumes and function.

Authors:  Pierre-André Vuissoz; Freddy Odille; Brice Fernandez; Maelene Lohezic; Adnane Benhadid; Damien Mandry; Jacques Felblinger
Journal:  J Magn Reson Imaging       Date:  2011-10-11       Impact factor: 4.813

2.  MRI Assessment of Ablation-Induced Scarring in Atrial Fibrillation: Analysis from the DECAAF Study.

Authors:  Nazem Akoum; David Wilber; Gerhard Hindricks; Pierre Jais; Josh Cates; Francis Marchlinski; Eugene Kholmovski; Nathan Burgon; Nan Hu; Lluis Mont; Thomas Deneke; Mattias Duytschaever; Thomas Neumann; Moussa Mansour; Christian Mahnkopf; Mathew Hutchinson; Bengt Herweg; Emile Daoud; Erik Wissner; Johannes Brachmann; Nassir F Marrouche
Journal:  J Cardiovasc Electrophysiol       Date:  2015-04-23

3.  Age, atrial fibrillation, and structural heart disease are the main determinants of left atrial fibrosis detected by delayed-enhanced magnetic resonance imaging in a general cardiology population.

Authors:  Hubert Cochet; Amaury Mouries; Hubert Nivet; Frederic Sacher; Nicolas Derval; Arnaud Denis; Mathilde Merle; Jatin Relan; Mélèze Hocini; Michel Haïssaguerre; François Laurent; Michel Montaudon; Pierre Jaïs
Journal:  J Cardiovasc Electrophysiol       Date:  2015-04-22

4.  Left atrial strain predicts reverse remodeling after catheter ablation for atrial fibrillation.

Authors:  Laurens F Tops; Victoria Delgado; Matteo Bertini; Nina Ajmone Marsan; Dennis W Den Uijl; Serge A I P Trines; Katja Zeppenfeld; Eduard Holman; Martin J Schalij; Jeroen J Bax
Journal:  J Am Coll Cardiol       Date:  2011-01-18       Impact factor: 24.094

5.  Relation of outcomes to ABC (Atrial Fibrillation Better Care) pathway adherent care in European patients with atrial fibrillation: an analysis from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry.

Authors:  Marco Proietti; Gregory Y H Lip; Cécile Laroche; Laurent Fauchier; Francisco Marin; Michael Nabauer; Tatjana Potpara; Gheorghe-Andrei Dan; Zbigniew Kalarus; Luigi Tavazzi; Aldo Pietro Maggioni; Giuseppe Boriani
Journal:  Europace       Date:  2021-02-05       Impact factor: 5.214

Review 6.  The pathogenesis of cardiac fibrosis.

Authors:  Ping Kong; Panagiota Christia; Nikolaos G Frangogiannis
Journal:  Cell Mol Life Sci       Date:  2013-05-07       Impact factor: 9.261

7.  Association of atrial fibrosis quantified using LGE-MRI with atrial appendage thrombus and spontaneous contrast on transesophageal echocardiography in patients with atrial fibrillation.

Authors:  Nazem Akoum; Genaro Fernandez; Brent Wilson; Christopher Mcgann; Eugene Kholmovski; Nassir Marrouche
Journal:  J Cardiovasc Electrophysiol       Date:  2013-07-11

8.  Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study.

Authors:  Luigi Di Biase; Pasquale Santangeli; Matteo Anselmino; Prasant Mohanty; Ilaria Salvetti; Sebastiano Gili; Rodney Horton; Javier E Sanchez; Rong Bai; Sanghamitra Mohanty; Agnes Pump; Mauricio Cereceda Brantes; G Joseph Gallinghouse; J David Burkhardt; Federico Cesarani; Marco Scaglione; Andrea Natale; Fiorenzo Gaita
Journal:  J Am Coll Cardiol       Date:  2012-08-07       Impact factor: 24.094

Review 9.  Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: A systematic review and meta-analysis.

Authors:  Vidar Ruddox; Irene Sandven; John Munkhaugen; Julie Skattebu; Thor Edvardsen; Jan Erik Otterstad
Journal:  Eur J Prev Cardiol       Date:  2017-06-15       Impact factor: 7.804

10.  Machine learning enables noninvasive prediction of atrial fibrillation driver location and acute pulmonary vein ablation success using the 12-lead ECG.

Authors:  Giorgio Luongo; Luca Azzolin; Steffen Schuler; Massimo W Rivolta; Tiago P Almeida; Juan P Martínez; Diogo C Soriano; Armin Luik; Björn Müller-Edenborn; Amir Jadidi; Olaf Dössel; Roberto Sassi; Pablo Laguna; Axel Loewe
Journal:  Cardiovasc Digit Health J       Date:  2021-04
View more
  2 in total

Review 1.  The Atrium in Atrial Fibrillation - A Clinical Review on How to Manage Atrial Fibrotic Substrates.

Authors:  Pedro Silva Cunha; Sérgio Laranjo; Jordi Heijman; Mário Martins Oliveira
Journal:  Front Cardiovasc Med       Date:  2022-07-04

2.  Left Atrial Strain Helps Identifying the Cardioembolic Risk in Transient Ischemic Attacks Patients with Silent Paroxysmal Atrial Fibrillation.

Authors:  Sergiu Florin Arnăutu; Vlad Ioan Morariu; Diana Aurora Arnăutu; Mirela Cleopatra Tomescu; Traian Flavius Dan; Cătălin Dragos Jianu
Journal:  Ther Clin Risk Manag       Date:  2022-03-10       Impact factor: 2.423

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.